To read this content please select one of the options below:

Misplaced marketing Misplaced fears of off label prescription drug marketing

Chester S. Galloway (Assistant Professor, School of Accountancy, Auburn University, Auburn, Alabama, USA)

Journal of Consumer Marketing

ISSN: 0736-3761

Article publication date: 1 November 2003

718

Abstract

The United State Food and Drug Administration gives approval for prescription drugs that are shown to be safe and effective to treat specific conditions. But once the drug is available, physicians can prescribe it for other “off label” uses, the positive therapeutic side effects that are discovered by the medical communities’ own information networks. The pharmaceutical manufacturers would like to be able to tell other doctors about these positive side effects, but they are barred from such “off label marketing” practices except under very narrow conditions.

Keywords

Citation

Galloway, C.S. (2003), "Misplaced marketing Misplaced fears of off label prescription drug marketing", Journal of Consumer Marketing, Vol. 20 No. 6, pp. 513-515. https://doi.org/10.1108/07363760310499084

Publisher

:

MCB UP Ltd

Copyright © 2003, MCB UP Limited

Related articles